ClinConnect ClinConnect Logo
Search / Trial NCT03512093

Improving SCBU Care for Preterm Babies

Launched by UNIVERSITY OF OXFORD · Apr 18, 2018

Trial Information

Current as of May 07, 2025

Completed

Keywords

Preterm Infant

ClinConnect Summary

This study aims to describe the neonatal clinical outcome of preterm neonates (\< 37+0 weeks of gestation) in terms of mortality and prematurity-related morbidity and the growth and neurodevelopment of preterm neonates (\< 34+0 weeks of gestation) in the first year of life in order to optimize service delivery for preterm neonates in a resource-constraint setting. The study will consist of 3 parts as follows:

Part A: A retrospective chart review of preterm neonates born in one of the birthing SMRU unit between January 2008 and December 2017 and for whom a medical chart is available. In add...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Part A: Neonatal medical record for preterm neonates (\< 37+0 weeks of gestation) in one of the SMRU clinics between January 2008 and December 2017
  • Part B: Male or female medical staff (Medics, midwives \& nurses) aged 18 years and above, who have been working for SMRU since the introduction of the Special Care Baby Unit (2008-2011) or after its establishment (2012-2017) and have actively cared for preterm newborns. Medical staff (Medics, midwives \& nurses) who have provided written informed consent and willing to participate to a Focus Group Discussion
  • Part C: Mothers, aged 18 years and above, who have had a preterm newborn (\< 37+0 weeks of gestation) admitted in SMRU clinics.
  • Multigravida or primigravid, presently in the SCBU or already discharged home who willing to discuss the broad topics include caring for the preterm newborn at home. Any mothers will be approached so that responses might provide a comprehensive overview of mothers concerns.
  • Mothers who have provided written informed consent and willing to participate to an interview
  • Exclusion Criteria:
  • • Parts A: Neonatal medical record of neonates \< 37+0 weeks of gestation receiving palliative care only.
  • Neonatal medical record of neonates \< 37+0 weeks of gestation born and hospitalized in tertiary hospital.
  • Neonatal medical record of neonates \< 37+0 weeks of gestation born at home and not hospitalized in SMRU clinics during the neonatal period.
  • Neonatal medical record of neonates \< 37+0 weeks of gestation born in SMRU clinics but transferred in tertiary hospital for further neonatal care.
  • Neonatal medical record of neonates born term (37+0 weeks or more)
  • Part B: Medical staff who has never been directly involved in caring for preterm neonates.
  • Part C: Mothers aged less than 18 years old

About University Of Oxford

The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.

Locations

Mae Sot, Tak, Thailand

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials